NCT03185143 - Low-Dose Naltrexone and Acetaminophen Combination and Sumatriptan in the Acute Treatment of Migraine With Nausea | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

May 7, 2018

Study Completion Date

May 7, 2018

Conditions

Migraine With and Without Aura

Interventions

DRUG

Naltrexone and Acetaminophen Combination

Treat a single Qualified Migraine attack.

DRUG

Sumatriptan 100 mg

One capsule contains Sumatriptan 100 mg and one capsule contains a sham for component B taken together to treat a single Qualified Migraine attack.

DRUG

Placebo

One capsule contains a sham for component A and one capsule contains a sham for component B taken together to treat a single Qualified Migraine attack.

Trial Locations (1)

33181

Annette C. Toledano, M.D., North Miami